Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Photo of Chris Lavy

The Technical Advisory Group on Integrated Clinical Care (the TAG-IC2) is a 22-strong member group of experts which advises WHO in the areas of clinical primary, emergency, operative, and critical care. Prof. Lavy is one of five members of a team that will advise WHO in the area of operative (surgical) care.  

“Our team will be reviewing guidelines, publications and other sorts of who materials in the surgical field and looking at setting out new ones if necessary,” said Chris. “In particular I’ll be looking at orthopaedics and trauma care.” 

One of Chris’s orthopaedic research interests is clubfoot and he’s set up the international Global Clubfoot Initiative to share expertise in clubfoot management. “We’ve discovered a lot about clubfoot through our studies, teaching and by delivering treatment to patients and children born with the condition. But as yet there is no global policy on its treatment. One of the reasons I’m part of the technical advisory group, is to help bring together some of the great ideas that have been tested across national programmes and diseases to be branded as global guidelines and protocols by the WHO.” 

The core functions of the TAG-IC2 are: 

  1. To provide independent evaluation of the scientific technical and strategic aspects of primary, emergency, operative, and critical care; 

  1. To advise WHO on the scope and characteristics of clinical care guidance documents; 

  1. To provide support and advice to WHO on evidence retrieval and synthesis; 

  1. To provide advice to WHO on validation of clinical recommendations through expert review; 

  1. To provide advice to WHO on validation of curricula and learning modules; 

  1. To identify areas where ad-hoc experts are needed to provide additional review. 

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.